Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-controlled, Double-blind Multicentre Study
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Metformin therapy reportedly benefits women with polycystic ovary syndrome (PCOS). Its effect is presumably based on lowering serum insulin levels. Metformin inhibits glucose production in the liver and also enhances insulin sensitivity at the cellular level. This prospective, randomized, double-blind, placebo-controlled study evaluated the effects of lifestyle change and metformin therapy in 143 women with PCOS who were oligomenorrheic or amenorrheic and had a body mass index (BMI) greater than 30 kg/m2. All patients received standard dietary advice and were placed on an individualized high-carbohydrate, low-fat diet. Metformin, given in a dose of 850 mg twice daily, was compared with placebo over 6 months. The 69 patients placed on metformin and the 74 given placebo had similar characteristics at baseline and had been infertile for similar periods. Menstrual cycles became significantly more frequent in both metformin-treated and placebo patients. The median improvement was one cycle per 6 months. Reductions in body weight and BMI were documented in both groups. None of these parameters differed significantly between the actively treated and placebo patients. In neither group did insulin sensitivity or lipid profiles change significantly. Patients given metformin had significant reductions in waist circumference and the free androgen index. On logistic regression analysis, considering metformin therapy, percentage of weight loss, initial BMI, and age, only the percentage weight loss correlated with improved menstrual function. There were 2 pregnancies in each group. In this trial, metformin did not enhance weight loss or menstrual frequency in obese patients with PCOS compared with placebo patients. Only weight loss during dietary management made menstruation more frequent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 3×
“The estimation of the QUICKI provides a robust and reproducible estimate of insulin sensitivity that shows excellent linear correlation with the gold standard clamp estimation with similar variability and discrimination power (Katz et al., 2000).”
BackgroundMethodInfluentialBonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients
Balen, A. H., Conway, G. S., Kaltsas, G., Techatraisak, K., Manning, P. J., West, C., & Jacobs, H. S. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136243 · Cited by 1,060
Self-citationUltrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Self-citationKiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921
Clark, A. M., Thornley, B., Tomlinson, L., Galletley, C., & Norman, R. J. (1998) · Human Reproduction · doi:10.1093/humrep/13.6.1502 · Cited by 789 · cited 2×
“Costello and Eden (2003) in their systematic review reached similar conclusions and again a wide range of entry criteria were reported.”
BackgroundClark, A. M., Ledger, W., Galletly, C., Tomlinson, L., Blaney, F., Wang, X., & Norman, R. J. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135772 · Cited by 642
Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635 · cited 3×
“As with our study, neither of the two RCT that reported an improvement in menstrual cyclicity showed a fall in BMI; both reported a fall in testosterone concentrations and only one an improvement in fasting insulin (Moghetti et al., 2000; Pasquali et al., 2000).”
BackgroundResultInfluentialDunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561 · cited 1×
“At least 40% of women with PCOS are obese (Balen et al., 1995) and they are more insulin resistant than weight-matched individuals with normal ovaries (Dunaif et al., 1995; Morales et al., 1996).”
Background
Cited by
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Palomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv025 · Cited by 334
Poly Cystic Ovarian Syndrome: An Updated Overview
El Hayek, S., Bitar, L., Hamdar, L. H., Mirza, F. G., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 323
Metadata
- Authors
- Tang, T., Glanville, J., Hayden, C. J., White, D., Barth, J. H., & Balen, A. H.
- Venue
- Obstetrical & Gynecological Survey
- Published
- 2006-02
- Volume
- 61
- Issue
- 2
- Pages
- 108-109
- ISSN
- 0029-7828 (ISSN-L)
- OpenAlex
- W1979153691
- Cited by
- 64
- References
- 17
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-controlled, Double-blind Multicentre Study. https://app.cochat.ai/papers/10.1097/01.ogx.0000197800.07214.dc
- The paper
- Tang, T., Glanville, J., Hayden, C. J., White, D., Barth, J. H., & Balen, A. H. (2006). Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-controlled, Double-blind Multicentre Study. Obstetrical & Gynecological Survey. https://doi.org/10.1097/01.ogx.0000197800.07214.dc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.